JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v2i1.2101 jpsim.v2i1.2101 Editorial Human Progress and Survival is Linked with Curiosity Akram Javed vc@uhs.edu.pk * Vice Chancellor, University of Health Sciences Lahore *Correspondence: Javed Akram (vc@uhs.edu.pk) 13 03 2021 2021 2 1 1 2 07 11 2020 20 01 2021 Copyright © 2021 The Author(s) 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 1 Ghosh RA. Appraisal of Microbial Evolution to Commensalism and Pathogenicity in Humans. Clin Med Insights Gastroenterol. 2013; 10.4137/CGast.S11858. 2 Childs EC, Calder CP, Miles AE. Diet and Immune Function. Nutrients. 2019;11(8):1933. 3 Hao X, Cheng S, Wu D, Wu T, Lin X, Wang C. Reconstruction of the full transmission dynamics of COVID-19 in Wuhan. Nature. 2020; 584(7821): 420–24. 4 Kim HJ, Marks F, Clemens DJ, Looking beyond COVID-19 vaccine phase 3 trials. Nature Medicine. 2021; 10.1038/s41591-021-01230-y. 5 World Health Organization. Different Types of COVID-19 vaccines. [Updated 2021, cited 2021] Available from: [https://www.who.int/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained] 6 Iavarone C, O’hagan DT, Yu D, Delahaye NF, Ulmer JB. Mechanism of action of mRNA-based vaccines. Expert Rev Vaccines. 2017;16(9):871-81 7 So DA, Woo J. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 2020; doi: 10.1136/bmj.m4750. 8 Huaxia. Pakistan in phase III trials of Chinese vaccine with expectation to see COVID-free future. [Updated 2021, cited 2021] available from. [http://www.xinhuanet.com/english/2021-01/19/c_139680671.htm] 9 US National Library of Medicine. A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19. [https://clinicaltrials.gov/ct2/show/NCT04646590